Zobrazeno 1 - 10
of 417
pro vyhledávání: '"Annett, M"'
Publikováno v:
In Journal of Immunological Methods 2011 363(2):187-197
Autor:
Jacobi, Annett M, Dörner, Thomas
Publikováno v:
In Current Opinion in Pharmacology 2010 10(3):316-321
Publikováno v:
PLoS ONE, Vol 4, Iss 6, p e5776 (2009)
DNA-reactive B cells play a central role in systemic lupus erythematosus (SLE); DNA antibodies precede clinical disease and in established disease correlate with renal inflammation and contribute to dendritic cell activation and high levels of type 1
Externí odkaz:
https://doaj.org/article/1fcf5df24be640bfa9efb79da659f9e7
Autor:
Odendahl, Marcus, Mei, Henrik, Hoyer, Bimba F., Jacobi, Annett M., Hansen, Arne, Muehlinghaus, Gwendolin, Berek, Claudia, Hiepe, Falk, Manz, Rudi, Radbruch, Andreas, Dörner, Thomas *
Publikováno v:
In Blood 15 February 2005 105(4):1614-1621
Publikováno v:
Scopus-Elsevier
Human-Machine Interfaces (HMI) are used where people and machines or systems (often within an industrial context) interact during a given task. The goal of this interaction is for the user to operate and control the machine in an effective manner, wh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02de4fa9209651086d6e4c1586478332
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Bosch, Annett M
Publikováno v:
Developmental period medicine, 22(3), 221-224. Instytut Matki i Dziecka
Developmental Period Medicine
Developmental Period Medicine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0fa1daead555ad5a734d3c730fd4d15f
https://pure.amc.nl/en/publications/galactosaemia--should-it-be-screened-in-newborns(b5a2b6d2-f005-4547-b0dc-c15a32a0b569).html
https://pure.amc.nl/en/publications/galactosaemia--should-it-be-screened-in-newborns(b5a2b6d2-f005-4547-b0dc-c15a32a0b569).html
Autor:
Michela Spadaro, Tilman Schneider-Hohendorf, Volker Siffrin, Xavier Montalban, Felix Luessi, Ester Cantó, Reinhard Hohlfeld, Renaud Du Pasquier, Ralf Gold, Frauke Zipp, Antonio Bertolotto, Dennis Görlich, Christoph Kleinschnitz, Nicholas Schwab, Béatrice Pignolet, Johanna Breuer, David Brassat, Anita Posevitz-Fejfar, Tania Kümpfel, Heinz Wiendl, Annett M. Jacobi, Sven G. Meuth, Susanne Windhagen, Björn Tackenberg, Manuel Comabella, Ingrid Meinl
Publikováno v:
Europe PubMed Central
Background: Natalizumab treatment is associated with progressive multifocal leukoencephalopathy (PML) development. Treatment duration, prior immunosuppressant use, and JCV serostatus are currently used for risk stratification, but PML incidence stays
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92a07a77c462dda217134f13728d4066
https://doi.org/10.1177/1352458515607651
https://doi.org/10.1177/1352458515607651
Autor:
Jacobi, Annett M.1, Jie Zhang1, Mackay, Meggan1, Aranow, Cynthia1, Diamond, Betty1 bdiamond@nshs.edu
Publikováno v:
PLoS ONE. 2009, Vol. 4 Issue 6, p1-10. 10p. 1 Chart, 5 Graphs.
Publikováno v:
In Value in Health May 2020 23 Supplement 1:S229-S229